Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

A cystic fibrosis patient developed Cushing's syndrome from a drug interaction between itraconazole and budesonide, which improved after stopping the medications.

Cepharanthine has many medicinal uses but needs improvement for better effectiveness.

Intralesional cidofovir might be a viable alternative treatment for certain conditions.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Eclipta alba extract reduces ulcers and protects the stomach in rats.

The committee decided not to approve the drug due to low effectiveness and high risks.

Pulmonary delivery of cepharanthine significantly improves its effectiveness and shows promise for treating lung fibrosis linked to COVID-19.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

Erlotinib causes skin inflammation through IL-1, which can be reduced by anakinra.

11β-Hydroxylase inhibitors help prevent seizures in mice by boosting natural neurosteroid production.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

A reliable method was developed to measure candesartan in human plasma.

Finasteride helps female-pattern hair loss.

Dicentrine reduced heart disease risk factors in rats, T-588 protected mice brains without side effects, Provir blocked herpes virus and lessened mouse symptoms, and LY191704 could treat hair loss and prostate issues.

Ritlecitinib is generally safe for alopecia areata patients over 72 months.

Protein Kinase C shows promise for cancer treatment, but more research is needed to develop effective inhibitors.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

A new test more accurately detects citrulline in hair follicles and pilomatrixomas.

N-acetylcysteine and ImuVert can prevent hair loss in rats caused by chemotherapy.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Ezetimibe effectively reduces prostate size in cases of benign prostatic hyperplasia.

The compound 4c effectively inhibits the enzyme linked to hair loss.

A woman with a type of hair loss saw hair regrowth after two months of taking baricitinib.